%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Hester Eppinga, H. Bing Thio, Marco W. J. Schreurs, Blerdi Blakaj, Ruena I. Tahitu, Sergey R. Konstantinov, Maikel P. Peppelenbosch, Gwenny M. Fuhler
Depletion of Saccharomyces cerevisiae in psoriasis patients, restored by Dimethylfumarate therapy (DMF)
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 13 0 R/Annots 14 0 R/Contents 15 0 R/TrimBox[0 0 612 792]>>
endobj
14 0 obj
[16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R]
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176955.ref001)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176955.ref002)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176955.ref003)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176955.ref004)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176955.ref005)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176955.ref005)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176955.ref006)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176955.ref007)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176955.ref008)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176955.ref009)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176955.ref010)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176955.ref011)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176955.ref012)>>
endobj
29 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176955.ref013)>>
endobj
30 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176955.ref014)>>
endobj
31 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176955.ref015)>>
endobj
32 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176955.ref016)>>
endobj
33 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176955.t001)>>
endobj
34 0 obj
<>/Border[0 0 0]/A 35 0 R>>
endobj
35 0 obj
<>
endobj
15 0 obj
[36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R 42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R 55 0 R 56 0 R]
endobj
36 0 obj
<>stream
q
0.83 0.64 0.02 0 k
316.6866 674.9858 m
321.4488 674.9858 l
h
f*
390.0472 649.0205 m
394.8094 649.0205 l
h
f*
399.2315 649.0205 m
403.9937 649.0205 l
h
f*
338.5134 610.0157 m
343.2756 610.0157 l
h
f*
253.8142 583.9937 m
258.5764 583.9937 l
h
f*
555.3071 544.989 m
560.0693 544.989 l
h
f*
564.4913 544.989 m
569.2535 544.989 l
h
f*
294.9732 505.9843 m
299.7354 505.9843 l
h
f*
304.1575 505.9843 m
308.9197 505.9843 l
h
f*
340.8378 493.0016 m
345.6 493.0016 l
h
f*
421.9087 480.0189 m
431.4331 480.0189 l
h
f*
522.7087 453.9969 m
532.2331 453.9969 l
h
f*
536.6551 453.9969 m
546.1795 453.9969 l
h
f*
377.1213 428.0315 m
386.6457 428.0315 l
h
f*
553.4929 402.0094 m
563.0173 402.0094 l
h
f*
200.0126 389.0268 m
209.537 389.0268 l
h
f*
227.3386 375.9874 m
236.8063 375.9874 l
h
f*
200.0126 107.9433 m
229.1528 107.9433 l
h
f*
0 g
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 706.0535 cm
BT
/F3 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 689.1023 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Psoriasis)Tj
3.7076 0 Td
(and)Tj
1.7292 0 Td
(inflammatory)Tj
5.7089 0 Td
(bowel)Tj
2.5852 0 Td
(disease)Tj
3.0217 0 Td
(\(IBD\))Tj
2.5568 0 Td
(are)Tj
1.4457 0 Td
(chronic)Tj
3.2882 0 Td
(inflammatory)Tj
5.7089 0 Td
(diseases)Tj
3.3789 0 Td
(sharing)Tj
-33.1311 -1.3039 Td
(similar)Tj
2.9876 0 Td
(pathogenic)Tj
4.6318 0 Td
(pathways[)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(].)Tj
5.3121 0 Td
(Both)Tj
2.1317 0 Td
(diseases)Tj
3.3788 0 Td
(are)Tj
1.4457 0 Td
(characterized)Tj
5.5615 0 Td
(by)Tj
1.1792 0 Td
(an)Tj
1.2019 0 Td
(increased)Tj
4.0025 0 Td
(inflammatory)Tj
-31.8328 -1.2982 Td
(response)Tj
3.7303 0 Td
(at)Tj
0.9525 0 Td
(the)Tj
1.4683 0 Td
(epithelial)Tj
3.8721 0 Td
(barrier.)Tj
3.1918 0 Td
(Secondly,)Tj
4.0535 0 Td
(similar)Tj
2.9877 0 Td
(genetic)Tj
3.0671 0 Td
(susceptibility)Tj
5.4425 0 Td
(plays)Tj
2.2336 0 Td
(an)Tj
1.2019 0 Td
(important)Tj
-32.2013 -1.2983 Td
(role)Tj
1.7688 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(development)Tj
5.4084 0 Td
(of)Tj
1.0148 0 Td
(both)Tj
2.058 0 Td
(disease)Tj
3.016 0 Td
(entities[)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
4.1499 0 Td
(3)Tj
0 g
(].)Tj
1.2643 0 Td
(A)Tj
0.9014 0 Td
(third)Tj
2.211 0 Td
(contributing)Tj
5.2497 0 Td
(factor)Tj
2.5455 0 Td
(to)Tj
1.0261 0 Td
(IBD)Tj
1.8766 0 Td
(devel-)Tj
-34.9963 -1.3039 Td
(opment)Tj
3.3335 0 Td
(is)Tj
0.8504 0 Td
(an)Tj
1.2018 0 Td
(altered)Tj
2.9424 0 Td
(intestinal)Tj
3.9118 0 Td
(microbial)Tj
4.0648 0 Td
(composition,)Tj
5.4652 0 Td
(with)Tj
2.0012 0 Td
(a)Tj
0.652 0 Td
(decreased)Tj
4.1386 0 Td
(abundance)Tj
4.5921 0 Td
(of)Tj
1.0148 0 Td
(several)Tj
-34.1686 -1.2983 Td
(commensal)Tj
4.8018 0 Td
(microbes)Tj
3.9005 0 Td
(\(e.g.)Tj
/F13 1 Tf
1.8992 0 Td
[()31()6()7()7()11()12()14()4()6()-4()11()2( )-9()12(\n)12()]TJ
6.9335 0 Td
[()11( )20()16(\n)-4(\r)10()18()14()12()]TJ
/F8 1 Tf
(\))Tj
4.7791 0 Td
(and)Tj
1.7292 0 Td
(an)Tj
1.2018 0 Td
(increase)Tj
3.4753 0 Td
(of)Tj
1.0148 0 Td
(pathogens)Tj
4.303 0 Td
(\(e.g.)Tj
-34.0382 -1.2982 Td
(adherent)Tj
3.7757 0 Td
(invasive)Tj
/F13 1 Tf
3.4299 0 Td
[()-4(\r)-3()13()6()2( )-9()4()13()18()4()]TJ
4.6261 0 Td
[()7()10()12()]TJ
/F8 1 Tf
(\)[)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(].)Tj
3.2825 0 Td
(Changes)Tj
3.6396 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4684 0 Td
(fungal)Tj
2.7325 0 Td
(microbial)Tj
4.0592 0 Td
(community)Tj
4.8869 0 Td
(are)Tj
1.4514 0 Td
(also)Tj
-34.3897 -1.304 Td
(common,)Tj
4.0705 0 Td
(with)Tj
1.9956 0 Td
(a)Tj
0.6519 0 Td
(decreased)Tj
/F13 1 Tf
4.1386 0 Td
[()-6()6()7()13()6()16( )20()11()24()3()7()8(\r)]TJ
6.0264 0 Td
[()7()2( )20()-5()-13()-4(\r)10()4()6()]TJ
/F8 1 Tf
3.9118 0 Td
(abundance)Tj
4.5977 0 Td
(as)Tj
1.0148 0 Td
(one)Tj
1.6952 0 Td
(of)Tj
1.0147 0 Td
(the)Tj
1.4741 0 Td
(most)Tj
2.2053 0 Td
(prominent)Tj
-32.7966 -1.2982 Td
(observations[)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(].)Tj
/F13 1 Tf
6.6386 0 Td
[()]TJ
/F8 1 Tf
(.)Tj
/F13 1 Tf
0.9015 0 Td
[()7()2( )20()-5()-13()-4(\r)10()4()6()]TJ
/F8 1 Tf
(,)Tj
4.1385 0 Td
(also)Tj
1.7688 0 Td
(called)Tj
2.5172 0 Td
(baker's)Tj
3.4242 0 Td
(yeast)Tj
2.5852 0 Td
(or)Tj
1.0942 0 Td
(brewer's)Tj
3.9684 0 Td
(yeast)Tj
2.5852 0 Td
(because)Tj
3.3222 0 Td
(of)Tj
1.0148 0 Td
(its)Tj
1.1452 0 Td
(usage)Tj
-35.104 -1.2983 Td
(in)Tj
1.0318 0 Td
(fermentative)Tj
5.2724 0 Td
(production)Tj
4.7168 0 Td
(of)Tj
1.0148 0 Td
(bread,)Tj
2.7099 0 Td
(beer)Tj
1.9445 0 Td
(or)Tj
1.0999 0 Td
(wine,)Tj
2.3641 0 Td
(is)Tj
0.8503 0 Td
(the)Tj
1.4684 0 Td
(most)Tj
2.2053 0 Td
(intensively)Tj
4.5127 0 Td
(studied)Tj
3.1578 0 Td
(eukaryotic)Tj
-32.3487 -1.2983 Td
(organism)Tj
3.9911 0 Td
(in)Tj
1.0375 0 Td
(literature)Tj
3.8834 0 Td
(and)Tj
1.7291 0 Td
(one)Tj
1.6952 0 Td
(of)Tj
1.0147 0 Td
(the)Tj
1.4741 0 Td
(most)Tj
2.2053 0 Td
(abundant)Tj
4.0422 0 Td
(yeasts)Tj
2.5568 0 Td
(in)Tj
1.0318 0 Td
(our)Tj
1.6271 0 Td
(gut.)Tj
/F13 1 Tf
1.7348 0 Td
[()]TJ
/F8 1 Tf
(.)Tj
/F13 1 Tf
0.9014 0 Td
[()7()2( )20()-5()-13()-4(\r)10()4()6()]TJ
/F8 1 Tf
3.9118 0 Td
(is)Tj
0.8504 0 Td
(known)Tj
3.0047 0 Td
(to)Tj
-36.6914 -1.3039 Td
(possess)Tj
3.1124 0 Td
(anti-inflammatory)Tj
7.6024 0 Td
(properties)Tj
4.2803 0 Td
(by)Tj
1.1792 0 Td
(being)Tj
2.4321 0 Td
(able)Tj
1.8312 0 Td
(to)Tj
1.0262 0 Td
(stimulate)Tj
3.8947 0 Td
(IL-10)Tj
2.3981 0 Td
(and)Tj
1.7348 0 Td
(inhibit)Tj
2.9027 0 Td
(TNF-)Tj
/F14 1 Tf
()Tj
/F8 1 Tf
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
4.0535 0 Td
(6)Tj
0 g
(].)Tj
-36.4476 -1.2982 Td
(Whether)Tj
3.7587 0 Td
(the)Tj
1.4683 0 Td
(fungal)Tj
2.7269 0 Td
(microbiome)Tj
5.1364 0 Td
(also)Tj
1.7688 0 Td
(plays)Tj
2.228 0 Td
(a)Tj
0.6576 0 Td
(role)Tj
1.7688 0 Td
(in)Tj
1.0318 0 Td
(psoriasis)Tj
3.668 0 Td
(is)Tj
0.8504 0 Td
(as)Tj
1.0148 0 Td
(yet)Tj
1.3947 0 Td
(unknown.)Tj
-26.277 -1.2983 Td
(Dimethylfumarate)Tj
7.5911 0 Td
(\(DMF\))Tj
3.0557 0 Td
(is)Tj
0.8504 0 Td
(an)Tj
1.2019 0 Td
(effective)Tj
3.5093 0 Td
(therapy)Tj
3.2484 0 Td
(for)Tj
1.389 0 Td
(psoriasis,)Tj
3.8891 0 Td
(and)Tj
1.7291 0 Td
(an)Tj
1.2019 0 Td
(emerging)Tj
4.0082 0 Td
(therapy)Tj
3.2428 0 Td
(for)Tj
-36.1131 -1.3039 Td
(multiple)Tj
3.5659 0 Td
(sclerosis)Tj
3.5376 0 Td
(\(MS\)[)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
3.3109 0 Td
(8)Tj
0 g
(].)Tj
1.2642 0 Td
(There)Tj
2.5739 0 Td
(is)Tj
0.8503 0 Td
(growing)Tj
3.5263 0 Td
(interest)Tj
3.2145 0 Td
(for)Tj
1.3833 0 Td
(the)Tj
1.474 0 Td
(implementation)Tj
6.6387 0 Td
(of)Tj
1.0148 0 Td
(DMF)Tj
2.3754 0 Td
(for)Tj
-34.7298 -1.2983 Td
(other)Tj
2.347 0 Td
(chronic)Tj
3.2882 0 Td
(diseases)Tj
3.3789 0 Td
(such)Tj
2.0579 0 Td
(as)Tj
1.0148 0 Td
(IBD[)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(],)Tj
3.2598 0 Td
(although)Tj
3.7531 0 Td
(the)Tj
1.4683 0 Td
(exact)Tj
2.2677 0 Td
(mechanisms)Tj
5.2044 0 Td
(of)Tj
1.0148 0 Td
(action,)Tj
2.9253 0 Td
(besides)Tj
-31.9802 -1.2982 Td
(immunomodulation,)Tj
8.6172 0 Td
(have)Tj
2.058 0 Td
(not)Tj
1.576 0 Td
(yet)Tj
1.3946 0 Td
(been)Tj
2.126 0 Td
(fully)Tj
1.9786 0 Td
(elucidated[)Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(].)Tj
6.1795 0 Td
(DMF)Tj
2.3754 0 Td
(has)Tj
1.542 0 Td
(been)Tj
2.126 0 Td
(also)Tj
1.7631 0 Td
(applied)Tj
3.1578 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
-35.909 -1.304 Td
(biocide)Tj
3.1407 0 Td
(in)Tj
1.0375 0 Td
(shoe)Tj
2.0353 0 Td
(soles,)Tj
2.347 0 Td
(clothes)Tj
3.0047 0 Td
(and)Tj
1.7348 0 Td
(furniture)Tj
3.8438 0 Td
(for)Tj
1.3833 0 Td
(prevention)Tj
4.5807 0 Td
(of)Tj
1.0148 0 Td
(mold)Tj
2.3188 0 Td
(growth.)Tj
3.2995 0 Td
(However,)Tj
4.0762 0 Td
(due)Tj
1.7007 0 Td
(to)Tj
-35.5178 -1.2982 Td
(allergic)Tj
3.0954 0 Td
(eczematous)Tj
4.8528 0 Td
(reactions,)Tj
4.0762 0 Td
(its)Tj
1.1509 0 Td
(use)Tj
1.5307 0 Td
(in)Tj
1.0318 0 Td
(these)Tj
2.2564 0 Td
(applications)Tj
5.0399 0 Td
(has)Tj
1.5421 0 Td
(been)Tj
2.1259 0 Td
(discontinued[)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
6.9619 0 Td
(12)Tj
0 g
(].)Tj
-32.4678 -1.2983 Td
(As)Tj
1.2699 0 Td
(IBD)Tj
1.8765 0 Td
(and)Tj
1.7291 0 Td
(psoriasis)Tj
3.6624 0 Td
(share)Tj
2.3414 0 Td
(similar)Tj
2.9877 0 Td
(pathogenic)Tj
4.6317 0 Td
(pathways,)Tj
4.1556 0 Td
(including)Tj
4.0422 0 Td
(similar)Tj
2.982 0 Td
(bacterial)Tj
3.6283 0 Td
(distur-)Tj
-34.503 -1.2983 Td
(bances)Tj
2.9139 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4684 0 Td
(gut)Tj
1.5136 0 Td
(as)Tj
1.0148 0 Td
(we)Tj
1.3267 0 Td
(have)Tj
2.0579 0 Td
(recently)Tj
3.4129 0 Td
(shown[)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
(],)Tj
4.7055 0 Td
(we)Tj
1.3266 0 Td
(speculated)Tj
4.405 0 Td
(that,)Tj
2.0012 0 Td
(as)Tj
1.0148 0 Td
(in)Tj
1.0375 0 Td
(IBD,)Tj
/F13 1 Tf
2.0976 0 Td
[()]TJ
/F8 1 Tf
(.)Tj
/F13 1 Tf
0.9014 0 Td
[()7()2( )20()-5()-13()-4(\r)10()4()6()]TJ
/F8 1 Tf
-32.2353 -1.3039 Td
(abundance)Tj
4.592 0 Td
(might)Tj
2.5966 0 Td
(be)Tj
1.1508 0 Td
(decreased)Tj
4.1386 0 Td
(in)Tj
1.0375 0 Td
(psoriasis.)Tj
3.8891 0 Td
(Interestingly,)Tj
5.4935 0 Td
(in)Tj
1.0318 0 Td
(Crohn's)Tj
3.4185 0 Td
(disease,)Tj
3.2429 0 Td
(anti-)Tj
/F13 1 Tf
[()-6()6()7()13()6()16( )20()11()24()]TJ
-30.5913 -1.2982 Td
[()7()8(\r)]TJ
1.3095 0 Td
[()7()2( )20()-5()-13()-4(\r)10()4()6()]TJ
/F8 1 Tf
3.9175 0 Td
(antibodies)Tj
4.3597 0 Td
(\(ASCAs\))Tj
3.7643 0 Td
(are)Tj
1.4514 0 Td
(significantly)Tj
5.091 0 Td
(elevated)Tj
3.4525 0 Td
(compared)Tj
4.2406 0 Td
(to)Tj
1.0262 0 Td
(healthy)Tj
3.1294 0 Td
(controls[)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
-31.7421 -1.2983 Td
(15)Tj
0 g
(].)Tj
1.7347 0 Td
(Recently,)Tj
3.8835 0 Td
(elevated)Tj
3.4526 0 Td
(ASCA)Tj
2.7269 0 Td
(levels)Tj
2.3754 0 Td
(have)Tj
2.0636 0 Td
(also)Tj
1.7631 0 Td
(been)Tj
2.126 0 Td
(demonstrated)Tj
5.76 0 Td
(in)Tj
1.0374 0 Td
(patients)Tj
3.3676 0 Td
(with)Tj
1.9956 0 Td
(spondyloar-)Tj
-32.2864 -1.3039 Td
(thritis[)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(],)Tj
4.4673 0 Td
(but)Tj
1.5534 0 Td
(in)Tj
1.0318 0 Td
(psoriasis)Tj
3.668 0 Td
(this)Tj
1.6724 0 Td
(has)Tj
1.5477 0 Td
(not)Tj
1.5704 0 Td
(been)Tj
2.126 0 Td
(studied.)Tj
-16.4408 -1.2983 Td
(In)Tj
-0.022 Tc
1.1111 0 Td
(this)Tj
1.6044 0 Td
(study)Tj
2.2961 0 Td
(we)Tj
1.2926 0 Td
(investigated)Tj
4.7735 0 Td
(whether)Tj
3.3505 0 Td
(psoriasis)Tj
3.5036 0 Td
(patients)Tj
3.2258 0 Td
(harbor)Tj
2.829 0 Td
(an)Tj
1.1679 0 Td
(altered)Tj
2.8176 0 Td
(faecal)Tj
/F13 1 Tf
2.3584 0 Td
[()]TJ
/F8 1 Tf
(.)Tj
/F13 1 Tf
0.8674 0 Td
[()7()2( )20()-5()-13()-4(\r)10()4()6()]TJ
/F8 1 Tf
3.7303 0 Td
(ab-)Tj
-36.1244 -1.2983 Td
(undance)Tj
3.5262 0 Td
(compared)Tj
4.0989 0 Td
(to)Tj
0.9921 0 Td
(healthy)Tj
3.0047 0 Td
(controls.)Tj
3.5433 0 Td
(Furthermore,)Tj
5.4028 0 Td
(in)Tj
/F13 1 Tf
0.9978 0 Td
[()-13()15()3()]TJ
/F8 1 Tf
1.7461 0 Td
(and)Tj
1.6781 0 Td
(in)Tj
/F13 1 Tf
0.9978 0 Td
[()-13()14()7( )20()]TJ
/F8 1 Tf
(,)Tj
2.1657 0 Td
(we)Tj
1.2926 0 Td
(investigated)Tj
4.7735 0 Td
(whether)Tj
-34.2196 -1.3039 Td
(DMF)Tj
2.3187 0 Td
(had)Tj
1.6554 0 Td
(impact)Tj
2.8743 0 Td
(on)Tj
1.2416 0 Td
(the)Tj
/F13 1 Tf
1.4116 0 Td
[()]TJ
/F8 1 Tf
(.)Tj
/F13 1 Tf
0.8674 0 Td
[()7()2( )20()-5()-13()-4(\r)10()4()6()]TJ
/F8 1 Tf
3.7304 0 Td
(abundance.)Tj
4.6431 0 Td
(In)Tj
1.0715 0 Td
(addition,)Tj
3.6623 0 Td
(ASCA)Tj
2.6532 0 Td
(levels)Tj
2.2678 0 Td
(were)Tj
2.0522 0 Td
(measured.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 300.0188 cm
BT
/F3 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Materials)Tj
4.5071 0 Td
(and)Tj
1.989 0 Td
(methods)Tj
/F0 1 Tf
-6.4961 -1.5023 Td
(Patients)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 264.9826 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(All)Tj
1.3946 0 Td
(patients)Tj
3.3675 0 Td
(were)Tj
2.126 0 Td
(included)Tj
3.7077 0 Td
(at)Tj
0.9524 0 Td
(the)Tj
1.474 0 Td
(outpatient)Tj
4.337 0 Td
(clinic)Tj
2.3981 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(Department)Tj
5.091 0 Td
(of)Tj
1.0148 0 Td
(Dermatology,)Tj
5.709 0 Td
(Erasmus)Tj
-34.0552 -1.2982 Td
(MC)Tj
1.7744 0 Td
(in)Tj
1.0375 0 Td
(Rotterdam,)Tj
4.7452 0 Td
(the)Tj
1.4683 0 Td
(Netherlands.)Tj
5.3461 0 Td
(The)Tj
1.7802 0 Td
(study)Tj
2.3924 0 Td
(was)Tj
1.6951 0 Td
(approved)Tj
3.9741 0 Td
(by)Tj
1.1849 0 Td
(the)Tj
1.4684 0 Td
(medical)Tj
3.3618 0 Td
(ethical)Tj
2.8403 0 Td
(committee)Tj
-33.0687 -1.2983 Td
(of)Tj
1.0147 0 Td
(the)Tj
1.4684 0 Td
(Erasmus)Tj
3.6623 0 Td
(MC)Tj
1.7802 0 Td
(\(MEC-2014-371\).)Tj
7.2793 0 Td
(Written)Tj
3.3902 0 Td
(informed)Tj
3.9742 0 Td
(consent)Tj
3.3335 0 Td
(was)Tj
1.6951 0 Td
(obtained)Tj
3.736 0 Td
(for)Tj
1.3833 0 Td
(all)Tj
1.1452 0 Td
(partici-)Tj
-33.8624 -1.3039 Td
(pants.)Tj
2.6021 0 Td
(Inclusion)Tj
3.9912 0 Td
(criteria)Tj
3.0784 0 Td
(were)Tj
2.1203 0 Td
(a)Tj
0.652 0 Td
(confirmed)Tj
4.3993 0 Td
(psoriasis)Tj
3.6623 0 Td
(diagnosis)Tj
3.9629 0 Td
(by)Tj
1.1792 0 Td
(a)Tj
0.6519 0 Td
(dermatologist,)Tj
5.9754 0 Td
(and)Tj
1.7291 0 Td
(age)Tj
-34.0041 -1.2983 Td
(between)Tj
3.5262 0 Td
(1875)Tj
2.6419 0 Td
(years.)Tj
2.4888 0 Td
(A)Tj
0.9014 0 Td
(minimum)Tj
4.2916 0 Td
(use)Tj
1.5307 0 Td
(of)Tj
1.0148 0 Td
(6)Tj
0.6974 0 Td
(weeks)Tj
2.6078 0 Td
(of)Tj
1.0148 0 Td
(DMF)Tj
2.3754 0 Td
(was)Tj
1.7008 0 Td
(required)Tj
3.6397 0 Td
(before)Tj
2.7382 0 Td
(inclusion)Tj
3.9175 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
-36.1244 -1.2982 Td
(study.)Tj
2.6135 0 Td
(Exclusion)Tj
4.1385 0 Td
(criteria)Tj
3.0728 0 Td
(were)Tj
2.1259 0 Td
(oral)Tj
1.7745 0 Td
(antibiotic)Tj
4.0365 0 Td
(use)Tj
1.5364 0 Td
(8)Tj
0.6916 0 Td
(weeks)Tj
2.6136 0 Td
(prior)Tj
2.2507 0 Td
(to)Tj
1.0261 0 Td
(inclusion,)Tj
4.1442 0 Td
(IBD-comorbidity,)Tj
-30.0243 -1.3039 Td
(history)Tj
3.0047 0 Td
(of)Tj
1.0148 0 Td
(bowel)Tj
2.5908 0 Td
(resection,)Tj
4.0649 0 Td
(pregnancy)Tj
4.4106 0 Td
(and)Tj
1.7292 0 Td
(active)Tj
2.5228 0 Td
(infection.)Tj
4.0138 0 Td
(Clinical)Tj
3.3165 0 Td
(data)Tj
1.9162 0 Td
(was)Tj
1.6951 0 Td
(collected)Tj
3.7418 0 Td
(regard-)Tj
-34.0212 -1.2983 Td
(ing)Tj
1.5023 0 Td
(medical)Tj
3.3562 0 Td
(history,)Tj
3.2371 0 Td
(comorbidities,)Tj
5.9925 0 Td
(medication,)Tj
4.9605 0 Td
(and)Tj
1.7292 0 Td
(disease)Tj
3.016 0 Td
(characteristics.)Tj
6.1342 0 Td
(Duration)Tj
3.9061 0 Td
(of)Tj
1.0148 0 Td
(DMF)Tj
-34.8489 -1.2983 Td
(use)Tj
1.5306 0 Td
(and)Tj
1.7292 0 Td
(presence)Tj
3.7133 0 Td
(of)Tj
1.0148 0 Td
(adverse-effects)Tj
6.0718 0 Td
(were)Tj
2.1203 0 Td
(recorded.)Tj
4.0252 0 Td
(Psoriasis)Tj
3.7077 0 Td
(Area)Tj
2.1316 0 Td
(and)Tj
1.7291 0 Td
(Severity)Tj
3.3902 0 Td
(Index)Tj
2.5229 0 Td
(\(PASI\))Tj
-33.6867 -1.2982 Td
(was)Tj
1.6951 0 Td
(used)Tj
2.0636 0 Td
(to)Tj
1.0261 0 Td
(assess)Tj
2.5172 0 Td
(disease)Tj
3.0217 0 Td
(activity)Tj
3.1181 0 Td
(\()Tj
/F15 1 Tf
0 Tc
(<)Tj
/F8 1 Tf
-0.004 Tc
(10)Tj
2.279 0 Td
(mild,)Tj
2.3074 0 Td
(1020)Tj
2.6419 0 Td
(moderate,)Tj
/F15 1 Tf
0 Tc
4.2462 0 Td
(>)Tj
/F8 1 Tf
-0.004 Tc
(20)Tj
1.9446 0 Td
(severe\).)Tj
3.2428 0 Td
(From)Tj
2.4491 0 Td
(every)Tj
2.3471 0 Td
(partic-)Tj
-34.8999 -1.304 Td
(ipant,)Tj
2.5114 0 Td
(the)Tj
1.4684 0 Td
(faecal)Tj
2.4661 0 Td
(sample)Tj
3.0217 0 Td
(was)Tj
1.7008 0 Td
(sent)Tj
1.8538 0 Td
(by)Tj
1.1792 0 Td
(mail)Tj
1.9899 0 Td
(and)Tj
1.7292 0 Td
(stored)Tj
2.7099 0 Td
(at)Tj
0.9467 0 Td
(-80)Tj
1.9162 0 Td
(Celsius)Tj
3.0728 0 Td
(within)Tj
2.8119 0 Td
(48)Tj
1.1679 0 Td
(hours.)Tj
-29.3497 -1.2982 Td
(A)Tj
0.907 0 Td
(total)Tj
2.0013 0 Td
(of)Tj
1.0148 0 Td
(49)Tj
1.1735 0 Td
(psoriasis)Tj
3.668 0 Td
(patients)Tj
3.3676 0 Td
(were)Tj
2.1203 0 Td
(included,)Tj
3.9401 0 Td
(of)Tj
1.0148 0 Td
(which)Tj
2.6475 0 Td
(the)Tj
1.4684 0 Td
(characteristics)Tj
5.9073 0 Td
(are)Tj
1.4514 0 Td
(depicted)Tj
3.6283 0 Td
(in)Tj
0.83 0.64 0.02 0 k
-35.5065 -1.2983 Td
(Table)Tj
2.4377 0 Td
(1)Tj
0 g
(.)Tj
0.9241 0 Td
(In)Tj
1.1055 0 Td
(total)Tj
2.0069 0 Td
(30)Tj
1.1736 0 Td
(samples)Tj
3.3789 0 Td
(were)Tj
2.1259 0 Td
(collected)Tj
3.7361 0 Td
(from)Tj
2.2053 0 Td
(psoriasis)Tj
3.668 0 Td
(patients)Tj
3.3675 0 Td
(without)Tj
3.3336 0 Td
(DMF.)Tj
2.6022 0 Td
(A)Tj
0.9014 0 Td
(total)Tj
2.0012 0 Td
(of)Tj
1.0148 0 Td
(28)Tj
-35.9827 -1.3039 Td
(samples)Tj
3.3788 0 Td
(were)Tj
2.126 0 Td
(collected)Tj
3.736 0 Td
(from)Tj
2.211 0 Td
(psoriasis)Tj
3.6624 0 Td
(patients)Tj
3.3675 0 Td
(with)Tj
2.0013 0 Td
(DMF.)Tj
2.6022 0 Td
(Of)Tj
1.2529 0 Td
(nine)Tj
2.0069 0 Td
(of)Tj
1.0148 0 Td
(these)Tj
2.2563 0 Td
(patients,)Tj
3.5943 0 Td
(two)Tj
1.7065 0 Td
(sam-)Tj
-34.9169 -1.2983 Td
(ples)Tj
1.7688 0 Td
(were)Tj
2.1203 0 Td
(collected,)Tj
3.9628 0 Td
(one)Tj
1.7007 0 Td
(sample)Tj
3.0218 0 Td
(before)Tj
2.7382 0 Td
(and)Tj
1.7348 0 Td
(one)Tj
1.6951 0 Td
(sample)Tj
3.0217 0 Td
(after)Tj
2.0353 0 Td
(\(69)Tj
2.0296 0 Td
(weeks\))Tj
2.948 0 Td
(start)Tj
1.9842 0 Td
(of)Tj
1.0148 0 Td
(DMF.)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 385.8519 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Depletion)Tj
4.3583 0 Td
(of)Tj
/F6 1 Tf
1.0417 0 Td
(S)Tj
/F0 1 Tf
(.)Tj
/F6 1 Tf
1.1551 0 Td
(cerevisiae)Tj
/F0 1 Tf
4.6347 0 Td
(in)Tj
0.978 0 Td
(psoriasis,)Tj
4.3654 0 Td
(restored)Tj
3.8268 0 Td
(by)Tj
1.2614 0 Td
(DMF)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01769)Tj
4.089 0 Td
(55)Tj
0 g
2.0906 0 Td
(May)Tj
2.0906 0 Td
(9,)Tj
1.0346 0 Td
(2017)Tj
35.7806 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
37 0 obj
<>stream
endstream
endobj
38 0 obj
<>stream
endstream
endobj
39 0 obj
<>stream
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
endstream
endobj
46 0 obj
<>stream
endstream
endobj
47 0 obj
<>stream
endstream
endobj
48 0 obj
<>stream
endstream
endobj
49 0 obj
<>stream
endstream
endobj
50 0 obj
<>stream
endstream
endobj
51 0 obj
<>stream
endstream
endobj
52 0 obj
<>stream
endstream
endobj
53 0 obj
<>stream
endstream
endobj
54 0 obj
<>stream
endstream
endobj
55 0 obj
<>stream
endstream
endobj
56 0 obj
<>stream
BT
66.402 0 Td
(11)Tj
ET
Q
endstream
endobj
57 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 13 0 R/Annots 62 0 R/Contents 63 0 R/TrimBox[0 0 612 792]>>
endobj
59 0 obj
<>
endobj
64 0 obj
<>stream
/CIDInit/ProcSet findresource begin
12 dict begin begincmap
/CMapName/Adobe-Identity-UCS def
/CIDSystemInfo<>def
/CMapType 2 def
1 begincodespacerange
<0000>
endcodespacerange
4 beginbfchar
<0024><0041>
<0026><0043>
<002A><0047>
<0037><0054>
endbfchar
endcmap
CMapName currentdict /CMap defineresource pop end end
endstream
endobj
65 0 obj
<>/FontDescriptor 66 0 R/DW 600>>
endobj
66 0 obj
<>
endobj
67 0 obj
<>stream
cvt a &@ fpgm62 h glyf&e5